Skip to content

Clinical trials

Phase 1/2 Ischemic Stroke trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 1/2 Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20191
20213
20231
20241
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Unknown status3
Not yet recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xuanwu Hospital, Beijing3
Capital Medical University2
Affiliated Hospital of Nantong University1
Chinese PLA General Hospital1
Dongzhimen Hospital, Beijing1
Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.1
Neurodawn Pharmaceutical Co., Ltd.1
Shanghai 6th People's Hospital1
Shanghai East Hospital1
Tasly Pharmaceutical Group Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke13
Brain Infarction1
Cerebral Infarction1
Edema1
Infarction, Anterior Cerebral Artery1
Infarction, Middle Cerebral Artery1
Infarction, Posterior Cerebral Artery1
Reperfusion Injury1
Stroke1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.